Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 可孚医疗致力于为用户提供终身信赖的医疗健康产品和一站式解决方案，拥有近万个型号及规格的产品，覆盖健康监测、康复辅具、呼吸支持、医疗护理及中医理疗五大领域，现已发展为集研发、生产、销售和服务为一体的全生命周期个人健康管理领先企业。目前公司已获多项国家级（部级）、省级荣誉，如国家级专精特新“小巨人”企业、高新技术企业等。近年来，“可孚”电商交易指数在医疗器械类目中长期保持行业领先，此外，还在全国数十个重点城市开设三百余家不同类型的自营门店，并通过携手五十余家百强连锁药房，入驻20余万家药店。未来，可孚不仅将聚焦主业、拓展医用领域，还将为全球消费者的健康生活赋能，致力于成为受人尊重的全球化医疗器械综合服务商。
Main Business 从事医疗器械研发、生产、销售和服务的全生命周期个人健康管理领先企业。
Legal Representative 张敏
Top Executives
董事长：张敏
副董事长：张志明
董事：贺邦杰,张志明,薛小桥
独立董事：温志浩,刘爱明,宁华波
Top 5 Shareholder
Shareholder name Nature Holding Date
长沙械字号医疗投资有限公司限售股40.66%31/03/2024
张敏限售股5.79%31/03/2024
长沙科源同创企业管理中心（有限合伙）限售股5.79%31/03/2024
张志明限售股+流通A股3.47%31/03/2024
广州丹麓股权投资管理有限公司－广州丹麓创业投资基金合伙企业（有限合伙）流通A股2.46%31/03/2024
Company Secretary 薛小桥
Solicitors 湖南启元律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 0731-85506600
Fax No 0731-85791199
Website www.cofoe.com.cn
Email investor@cofoe.com
Company Address
Register: 湖南省长沙市雨花区振华路816号
Office: 湖南省长沙市雨花区振华路816号
Listing Date 25/10/2021
Shares Capital
Shares Capital: 209,238,250
Total A Share: 209,238,250
Listed A Share: 90,574,318
Non-tradable A Share: 118,663,932
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.240
DPS(RMB)* ¥ 1.200
NBV Per Share(RMB)* ¥ 23.414
Market Capitalization(RMB) 3.537B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.